TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Thursday reported third-quarter net income of $1.63 billion.

On a per-share basis, the Tarrytown, New York-based company said it had net income of $14.33. Earnings, adjusted for one-time gains and costs, came to $15.37 per share.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $9.81 per share.

The biopharmaceutical company posted revenue of $3.45 billion in the period, also exceeding Street forecasts. Seven analysts surveyed by Zacks expected $2.69 billion.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REGN at https://www.zacks.com/ap/REGN

Copyright by Automated Insights, Inc. All rights reserved.

Trending Food Videos